StemCell Institute
7096 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区虎ノ門一丁目２１番１９号
- Website:
- https://www.stemcell.co.jp/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
StemCell Institute is a premier private cord blood bank based in Japan, boasting over 25 years of expertise and a market-leading share of over 99%. Specializing in the collection and storage of umbilical cord blood and tissue, the institute offers a safe, painless collection process immediately after birth. Its state-of-the-art facilities ensure the preservation of vital stem cells, which are pivotal in regenerative medicine and potential treatments for conditions like leukemia, cerebral palsy, and autism spectrum disorders. With more than 80,000 cord blood units stored and recognized as ISO 9001 certified, StemCell Institute is committed to advancing medical research and enhancing future treatment options for families. Its innovative services include the storage of umbilical cord-derived mesenchymal stem cells, further expanding therapeutic possibilities.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 08:41 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.7 KB | |
| 2025-06-26 08:37 |
Inside Information Statement
臨時報告書
|
Japanese | 23.2 KB | |
| 2025-06-24 08:36 |
Internal Control over Financial Reporting
内部統制報告書－第26期(2024/04/01－2025/03/31)
|
Japanese | 22.6 KB | |
| 2025-06-24 08:35 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-24 08:33 |
Annual Report
有価証券報告書－第26期(2024/04/01－2025/03/31)
|
Japanese | 1017.9 KB | |
| 2025-06-02 08:39 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.4 KB | |
| 2025-05-01 09:38 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.4 KB | |
| 2025-04-01 08:27 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.8 KB | |
| 2025-03-04 08:55 |
Regulatory News Service
訂正自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 31.8 KB | |
| 2025-03-03 07:31 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.4 KB | |
| 2025-02-05 03:35 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 21.8 KB | |
| 2025-02-04 07:59 |
Inside Information Statement
臨時報告書
|
Japanese | 26.7 KB | |
| 2025-01-14 07:33 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 21.8 KB | |
| 2024-11-14 07:33 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-11-14 07:31 |
Interim Report
半期報告書－第26期(2024/04/01－2025/03/31)
|
Japanese | 189.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
D.Western Therapeutics Institute, Inc. | Japan | 4576 | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
EIKEN CHEMICAL CO.,LTD. | Japan | 4549 | |
|
Eisai Co., Ltd. | Japan | 4523 | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV | |
|
Enorama Pharma AB | Sweden | ERMA | |
|
Enzymatica AB | Sweden | ENZY |